Evaluating the prevalence and predictive factors of vasomotor and psychological symptoms in prostate cancer patients receiving hormonal therapy: Results from a single institution experience.

Challapalli, Amarnath; Edwards, Steve M; Abel, Paul; Mangar, Stephen A

Challapalli, Amarnath; Edwards, Steve M; Abel, Paul; Mangar, Stephen A.

Afiliação

Challapalli A; Department of Oncology, Imperial College Healthcare NHS Trust, London, UK.
Edwards SM; NIHR Clinical Research Network North West London, Imperial College Healthcare NHS Trust, London, UK.
Abel P; Department of Surgery and Cancer, Imperial College London, UK.
Mangar SA; Department of Oncology, Imperial College Healthcare NHS Trust, London, UK.

Clin Transl Radiat Oncol ; 10: 29-35, 2018 Mar.

Article em En | MEDLINE | ID: mdl-29928703

Palavras-chave

Hormone therapy; Predictive factors; Prostate cancer; Vasomotor symptoms

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Clin Transl Radiat Oncol Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google